KLRB1 and cancer: Analysis based on TCGA and GTEx data showed that CD161 expression was increased in most cancers including ACC, BLCA, CESC, CHOL, COAD, ESCA, GBM, HNSC, KIRC, LAML, LGG, LUSC, OV, PAAD, PRAD, SKCM, STAD, TGCT, THCA, and UCS compared with adjacent normal controls.